Rx Dynamic Total Return Fund

Scorecard
1 / 5 Stars
Lipper
1 1 4 1 5
Zacks Investment Research
---
Standard & Poor's
1 / 5 Stars
TheStreet.com
D (Sell)

U.S. News evaluated 278 Intermediate-Term Bond Funds. Our list highlights the top-rated funds for long-term investors based on the ratings of leading fund industry researchers.

See all FolioMetrix funds

See full Intermediate-Term Bond rankings

See more fund rankings

Performance

The fund has returned -0.32 percent over the past year, and 1.42 percent over the past three years.

Trailing Returns Updated 03.31.2014
Year to date 0.7%
1 Year -0.3%
3 Years (Annualized) 1.4%
5 Years (Annualized) N/A
10 Years (Annualized) N/A

See more FMTCX performance

Summary

The investment seeks total return through a combination of capital appreciation and current income. The fund invests in no-load, institutional, and exchange-traded funds that are registered under the Investment Company Act of 1940 and not affiliated with the fund or making direct investments in portfolio securities based upon institutional research, recommendations, and trading signals from investment model managers or other third-party research providers. The Portfolio will be comprised of fixed income securities, principally consisting of bonds, corporate debt securities, convertible securities, Treasury Inflation-Protected Securities, and other treasuries.

Fees

Fees are High compared to funds in the same category.
Rx Dynamic Total Return Fund has an expense ratio of 1.84 percent.

See more FMTCX fees

Risk

Risk is Low compared to funds in the same category according to Morningstar.

See more FMTCX risk